These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19204991)

  • 1. Collective behavior in cancer cell populations.
    Deisboeck TS; Couzin ID
    Bioessays; 2009 Feb; 31(2):190-7. PubMed ID: 19204991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of ephrins in regulation of tumour cell migration].
    Wybieralska E; Łaczna E; Madeja Z
    Postepy Biochem; 2009; 55(2):153-62. PubMed ID: 19824471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sense and Sensitivity: Physical Limits to Multicellular Sensing, Migration, and Drug Response.
    Varennes J; Mugler A
    Mol Pharm; 2016 Jul; 13(7):2224-32. PubMed ID: 26835969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does cancer growth depend on surface extension?
    Deisboeck TS; Guiot C; Delsanto PP; Pugno N
    Med Hypotheses; 2006; 67(6):1338-41. PubMed ID: 16828232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collective cell migration in development.
    Weijer CJ
    J Cell Sci; 2009 Sep; 122(Pt 18):3215-23. PubMed ID: 19726631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Types of tumor cells movement].
    Popow-Woźniak A; Nowak D; Malicka-Błaszkiewicz M
    Postepy Biochem; 2009; 55(2):113-20. PubMed ID: 19824466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.
    Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A
    J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
    Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of collective cell migration at a glance.
    Ilina O; Friedl P
    J Cell Sci; 2009 Sep; 122(Pt 18):3203-8. PubMed ID: 19726629
    [No Abstract]   [Full Text] [Related]  

  • 11. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of collective migration patterns of invasive breast cancer cells emerging during microtrack invasion.
    Liu R; Song K; Hu Z; Cao W; Shuai J; Chen S; Nan H; Zheng Y; Jiang X; Zhang H; Han W; Liao Y; Qu J; Jiao Y; Liu L
    Phys Rev E; 2019 Jun; 99(6-1):062403. PubMed ID: 31330694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cancer properties of low-molecular-weight heparin: preclinical evidence.
    Mousa SA; Petersen LJ
    Thromb Haemost; 2009 Aug; 102(2):258-67. PubMed ID: 19652876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMT 2.0: shaping epithelia through collective migration.
    Revenu C; Gilmour D
    Curr Opin Genet Dev; 2009 Aug; 19(4):338-42. PubMed ID: 19464162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TrkA overexpression enhances growth and metastasis of breast cancer cells.
    Lagadec C; Meignan S; Adriaenssens E; Foveau B; Vanhecke E; Romon R; Toillon RA; Oxombre B; Hondermarck H; Le Bourhis X
    Oncogene; 2009 May; 28(18):1960-70. PubMed ID: 19330021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90.
    Koga F; Kihara K; Neckers L
    Anticancer Res; 2009 Mar; 29(3):797-807. PubMed ID: 19414312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells.
    Kim A; Kim MJ; Yang Y; Kim JW; Yeom YI; Lim JS
    Carcinogenesis; 2009 Jun; 30(6):927-36. PubMed ID: 19336468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF).
    Lin SS; Lai KC; Hsu SC; Yang JS; Kuo CL; Lin JP; Ma YS; Wu CC; Chung JG
    Cancer Lett; 2009 Nov; 285(2):127-33. PubMed ID: 19477063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contact inhibition revisited.
    Heckman CA
    J Cell Physiol; 2009 Sep; 220(3):574-5. PubMed ID: 19365807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
    Fujisawa T; Joshi B; Nakajima A; Puri RK
    Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.